Cohort Strengths and Limitations
Cross-source consensus on Cohort Strengths and Limitations from 1 sources and 6 claims.
1 sources · 6 claims
Benefits
Risks & contraindications
Highlighted claims
- Vaccination assessment before 2008 is incomplete because standardised nationwide billing codes were not fully implemented. — German Million Children Cohort: a historical birth cohort based on claims data to investigate the impact of immunisation and other early life factors on the risk of cancer and other diseases in childhood – cohort profile
- Private health insurance data are absent and the AOK-insured population is under-represented. — German Million Children Cohort: a historical birth cohort based on claims data to investigate the impact of immunisation and other early life factors on the risk of cancer and other diseases in childhood – cohort profile
- The cohort's large scale allows more precise association estimates than many previous studies and enables analysis of rare childhood cancer sites and specific vaccine types. — German Million Children Cohort: a historical birth cohort based on claims data to investigate the impact of immunisation and other early life factors on the risk of cancer and other diseases in childhood – cohort profile
- Maternal linkage for about 78% of children enables analysis of prenatal exposures. — German Million Children Cohort: a historical birth cohort based on claims data to investigate the impact of immunisation and other early life factors on the risk of cancer and other diseases in childhood – cohort profile
- ICD-10 cancer codes provide limited detail about histology and molecular cancer characteristics. — German Million Children Cohort: a historical birth cohort based on claims data to investigate the impact of immunisation and other early life factors on the risk of cancer and other diseases in childhood – cohort profile
- Long follow-up of up to 18 years supports detection of cancers in later childhood and adolescence. — German Million Children Cohort: a historical birth cohort based on claims data to investigate the impact of immunisation and other early life factors on the risk of cancer and other diseases in childhood – cohort profile